Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jan 6;21(1):9-10.
doi: 10.1016/j.cmet.2014.12.016.

Dysfunctional families: Clostridium scindens and secondary bile acids inhibit the growth of Clostridium difficile

Affiliations
Comment

Dysfunctional families: Clostridium scindens and secondary bile acids inhibit the growth of Clostridium difficile

K Leigh Greathouse et al. Cell Metab. .

Abstract

C. difficile infection is a deadly disease that is influenced by the microbiome. In a recent article in Nature, Buffie et al. (2014) demonstrate that the ability of C. scindens to synthesize secondary bile acids is crucial to providing resistance to C. difficile infection.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. S.scidens and Secondary Bile Acids Inhibit C.difficile Growth
(Left) inthe absence of antibiotics, the gut microbial community is diverse and includes bacteria such as S.scindens that convert primary bile acids into secondary bile acids, whcih, in turn, inhibits the growth of C.diffile. (Right) Broad-spectrum antibiotics diminish the diversity of the gut microbial community. Loss of certain bacteria such as C.scindens results in reduced production of secondary bile acids and increased growth of C.difficile. Additionally, accumulation of primary bile acids leads to increased spore germination of C.difficile.

Comment on

References

    1. Buffie GG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinne- brew M, Viale A, et al. (2014). Nature. Published online October 22, 2014 10.1038/nature13828. - DOI - PubMed
    1. Dubberke E (2012). J. Hosp. Med. 7 (Suppl 3), S1–S4. - PubMed
    1. Francis MB, Allen CA, Shrestha R, and Sorg JA (2013). PLoS Pathog. 9, e1003356. - PMC - PubMed
    1. Furusawa Y, Obata Y, Fukuda S, Endo TA, Na- kato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. (2013). Nature 504, 446–450 - PubMed
    1. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, et al. (2012). PLoS Pathog. 8, e1002995. - PMC - PubMed

Substances